Expanding the Scope of Community Pharmacy Practice in Nova Scotia: Impacts on Provincial COVID-19 Response

Nova Scotia has expanded the scope of practice for community pharmacists by allowing, among other changes, pharmacist prescribing under specific circumstances (2011) and administration of drugs by injection (2013), thereby alleviating stress on the health system. Due to these progressive expansions...

Full description

Bibliographic Details
Main Authors: Ingrid Sketris, Andrea Bishop, Tasha Ramsey, Jennifer Isenor, Chiranjeev Sanyal
Format: Article
Language:English
Published: McMaster University Library Press 2023-09-01
Series:Health Reform Observer - Observatoire des Réformes de Santé
Subjects:
Online Access:https://mulpress.mcmaster.ca/hro-ors/article/view/5403/4505
_version_ 1797692995269558272
author Ingrid Sketris
Andrea Bishop
Tasha Ramsey
Jennifer Isenor
Chiranjeev Sanyal
author_facet Ingrid Sketris
Andrea Bishop
Tasha Ramsey
Jennifer Isenor
Chiranjeev Sanyal
author_sort Ingrid Sketris
collection DOAJ
description Nova Scotia has expanded the scope of practice for community pharmacists by allowing, among other changes, pharmacist prescribing under specific circumstances (2011) and administration of drugs by injection (2013), thereby alleviating stress on the health system. Due to these progressive expansions in community pharmacy scope of practice, Nova Scotia community pharmacy personnel (about 1,500 pharmacists and 246 technicians working in 315 pharmacies) were rapidly able to play key roles in the province’s response to the COVID-19 pandemic. Community pharmacies provided medicines, medical devices, personal protective equipment, hand hygiene solutions, thermometers, and pulse oximeters to patients and the public. In addition, they have responded to patients’ COVID-19-related needs by treating symptoms; providing referrals; discussing the benefits and risks of COVID-19 vaccines and administering them; making nirmatrelvir/ritonavir assessments; and addressing vaccine hesitancy and the spread of misinformation about COVID-19. Moreover, as in some other provinces, community pharmacists in Nova Scotia have played a leading role in delivering COVID-19 vaccines from almost the start of the vaccination campaign in December 2020. Their role expanded further in May 2022, when pharmacists were granted prescribing authority for inhaled budesonide in accordance with the provincial protocol to treat mild SARS-CoV-2 respiratory symptoms. La Nouvelle-Écosse a élargi le champ d’exercice des pharmaciens communautaires en autorisant, entre autres, la prescription par un pharmacien dans des circonstances spécifiques (2011) et l’administration de médicaments par injection (2013), soulageant ainsi le système de santé. Grâce à ces élargissements progressifs du champ d’exercice des pharmacies communautaires, le personnel des pharmacies communautaires de Nouvelle-Écosse (environ 1 500 pharmaciens et 246 techniciens travaillant dans 315 pharmacies) a pu contribuer de manière cruciale et rapide à la réponse de la province à la pandémie de COVID-19. Les pharmacies communautaires ont fourni des médicaments, des dispositifs médicaux, des équipements de protection individuelle, des solutions pour l’hygiène des mains, des thermomètres et des oxymètres de pouls aux patients et au public. En outre, elles ont répondu aux besoins des patients liés à la COVID-19 en traitant les symptômes, en orientant les patients, en discutant des avantages et des risques des vaccins contre la COVID-19 et de leur administration, en évaluant la pertinence de traiter certains patients au nirmatrelvir/ritonavir et en répondant à l’hésitation vaccinale et à la diffusion d’informations erronées sur la COVID-19. De plus, les pharmaciens communautaires de Nouvelle-Écosse, comme ceux d’autres provinces, ont joué un rôle de premier plan dans l’administration des vaccins contre la COVID-19 dès le début de la campagne de vaccination en décembre 2020. Leur rôle s’est encore élargi en mai 2022, lorsque les pharmaciens ont été autorisés à prescrire du budésonide inhalé, conformément au protocole provincial, pour traiter les symptômes respiratoires légers du SRAS-CoV-2.
first_indexed 2024-03-12T02:36:09Z
format Article
id doaj.art-387d58f52b1a402c9c48dfa304fb0c3b
institution Directory Open Access Journal
issn 2291-6369
language English
last_indexed 2024-03-12T02:36:09Z
publishDate 2023-09-01
publisher McMaster University Library Press
record_format Article
series Health Reform Observer - Observatoire des Réformes de Santé
spelling doaj.art-387d58f52b1a402c9c48dfa304fb0c3b2023-09-04T14:37:15ZengMcMaster University Library PressHealth Reform Observer - Observatoire des Réformes de Santé2291-63692023-09-01111https://doi.org/10.13162/hro-ors.v11i1.5403Expanding the Scope of Community Pharmacy Practice in Nova Scotia: Impacts on Provincial COVID-19 ResponseIngrid Sketris0https://orcid.org/0000-0003-1820-5883Andrea Bishop1https://orcid.org/0000-0001-9215-7272Tasha Ramsey2https://orcid.org/0000-0002-9435-9377Jennifer Isenor3https://orcid.org/0000-0003-1648-7362Chiranjeev Sanyal4https://orcid.org/0000-0003-3677-8036Dalhousie UniversityNova Scotia College of PharmacistsDalhousie UniversityDalhousie UniversityDalhousie UniversityNova Scotia has expanded the scope of practice for community pharmacists by allowing, among other changes, pharmacist prescribing under specific circumstances (2011) and administration of drugs by injection (2013), thereby alleviating stress on the health system. Due to these progressive expansions in community pharmacy scope of practice, Nova Scotia community pharmacy personnel (about 1,500 pharmacists and 246 technicians working in 315 pharmacies) were rapidly able to play key roles in the province’s response to the COVID-19 pandemic. Community pharmacies provided medicines, medical devices, personal protective equipment, hand hygiene solutions, thermometers, and pulse oximeters to patients and the public. In addition, they have responded to patients’ COVID-19-related needs by treating symptoms; providing referrals; discussing the benefits and risks of COVID-19 vaccines and administering them; making nirmatrelvir/ritonavir assessments; and addressing vaccine hesitancy and the spread of misinformation about COVID-19. Moreover, as in some other provinces, community pharmacists in Nova Scotia have played a leading role in delivering COVID-19 vaccines from almost the start of the vaccination campaign in December 2020. Their role expanded further in May 2022, when pharmacists were granted prescribing authority for inhaled budesonide in accordance with the provincial protocol to treat mild SARS-CoV-2 respiratory symptoms. La Nouvelle-Écosse a élargi le champ d’exercice des pharmaciens communautaires en autorisant, entre autres, la prescription par un pharmacien dans des circonstances spécifiques (2011) et l’administration de médicaments par injection (2013), soulageant ainsi le système de santé. Grâce à ces élargissements progressifs du champ d’exercice des pharmacies communautaires, le personnel des pharmacies communautaires de Nouvelle-Écosse (environ 1 500 pharmaciens et 246 techniciens travaillant dans 315 pharmacies) a pu contribuer de manière cruciale et rapide à la réponse de la province à la pandémie de COVID-19. Les pharmacies communautaires ont fourni des médicaments, des dispositifs médicaux, des équipements de protection individuelle, des solutions pour l’hygiène des mains, des thermomètres et des oxymètres de pouls aux patients et au public. En outre, elles ont répondu aux besoins des patients liés à la COVID-19 en traitant les symptômes, en orientant les patients, en discutant des avantages et des risques des vaccins contre la COVID-19 et de leur administration, en évaluant la pertinence de traiter certains patients au nirmatrelvir/ritonavir et en répondant à l’hésitation vaccinale et à la diffusion d’informations erronées sur la COVID-19. De plus, les pharmaciens communautaires de Nouvelle-Écosse, comme ceux d’autres provinces, ont joué un rôle de premier plan dans l’administration des vaccins contre la COVID-19 dès le début de la campagne de vaccination en décembre 2020. Leur rôle s’est encore élargi en mai 2022, lorsque les pharmaciens ont été autorisés à prescrire du budésonide inhalé, conformément au protocole provincial, pour traiter les symptômes respiratoires légers du SRAS-CoV-2.https://mulpress.mcmaster.ca/hro-ors/article/view/5403/4505covid-19pandemicpharmacistscope of practiceprimary careimmunizationvaccinecommunity pharmacydrug interactionsreimbursement
spellingShingle Ingrid Sketris
Andrea Bishop
Tasha Ramsey
Jennifer Isenor
Chiranjeev Sanyal
Expanding the Scope of Community Pharmacy Practice in Nova Scotia: Impacts on Provincial COVID-19 Response
Health Reform Observer - Observatoire des Réformes de Santé
covid-19
pandemic
pharmacist
scope of practice
primary care
immunization
vaccine
community pharmacy
drug interactions
reimbursement
title Expanding the Scope of Community Pharmacy Practice in Nova Scotia: Impacts on Provincial COVID-19 Response
title_full Expanding the Scope of Community Pharmacy Practice in Nova Scotia: Impacts on Provincial COVID-19 Response
title_fullStr Expanding the Scope of Community Pharmacy Practice in Nova Scotia: Impacts on Provincial COVID-19 Response
title_full_unstemmed Expanding the Scope of Community Pharmacy Practice in Nova Scotia: Impacts on Provincial COVID-19 Response
title_short Expanding the Scope of Community Pharmacy Practice in Nova Scotia: Impacts on Provincial COVID-19 Response
title_sort expanding the scope of community pharmacy practice in nova scotia impacts on provincial covid 19 response
topic covid-19
pandemic
pharmacist
scope of practice
primary care
immunization
vaccine
community pharmacy
drug interactions
reimbursement
url https://mulpress.mcmaster.ca/hro-ors/article/view/5403/4505
work_keys_str_mv AT ingridsketris expandingthescopeofcommunitypharmacypracticeinnovascotiaimpactsonprovincialcovid19response
AT andreabishop expandingthescopeofcommunitypharmacypracticeinnovascotiaimpactsonprovincialcovid19response
AT tasharamsey expandingthescopeofcommunitypharmacypracticeinnovascotiaimpactsonprovincialcovid19response
AT jenniferisenor expandingthescopeofcommunitypharmacypracticeinnovascotiaimpactsonprovincialcovid19response
AT chiranjeevsanyal expandingthescopeofcommunitypharmacypracticeinnovascotiaimpactsonprovincialcovid19response